Leading the Way in Life Science Technologies

GEN Exclusives

More »

Tutorials

More »
Feb 15, 2009 (Vol. 29, No. 4)

Tools That Facilitate Metabolite Identification

Mass Spec Technology Drives Drug Metabolism Studies Forward

  • Outlook

    Click Image To Enlarge +
    Figure 4. Full MS spectrum at 8.45 minutes

    Mass spectrometry has undergone major advances in recent years and is reshaping the landscape in which drug companies perform their metabolite identification studies. Pharmaceutical organizations have come to expect instruments that require minimal user intervention, offer high-throughput analysis and provide high-quality data. With the bottleneck in the process shifting to data processing, data-reduction techniques must continue to evolve to meet this challenge.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »